A Study of AZD0120 in Autoimmune Diseases | MicrobiomeTrials← Back to trialsNCT07295847
A Study of AZD0120 in Autoimmune Diseases
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2026-01-09Est. Completion: 2028-02-22
Enrollment target: 27 participants Locations- Research Site, Tucson, Arizona, United States
- Research Site, Stanford, California, United States
- Research Site, Chicago, Illinois, United States
- Research Site, Ann Arbor, Michigan, United States
- Research Site, St Louis, Missouri, United States
- Research Site, New York, New York, United States
- Research Site, Chapel Hill, North Carolina, United States
- Research Site, Seattle, Washington, United States
- Research Site, Darlinghurst, Australia
- Research Site, Waratah, Australia
- Research Site, Berlin, Germany
- Research Site, Erlangen, Germany
- Research Site, Hamburg, Germany
- Research Site, Jena, Germany
- Research Site, Mainz, Germany
- Research Site, Würzburg, Germany
- Research Site, Barcelona, Spain
- Research Site, Madrid, Spain
- Research Site, Madrid, Spain
- Research Site, Huddinge, Sweden
- Research Site, Edinburgh, United Kingdom
Other microbiome trials you might be interested in
Systemic Sclerosis (SSc)
A pilot single center randomized trial to test whether a full-scale RCT evaluating the role of post-AHSCT maintenance im…
Ottawa, CanadaEst. completion Dec 2028
Autoimmune Diseases
Background:
Autoimmune diseases can be caused by genes people inherit from their parents. The gene changes that cause t…
Bethesda, United StatesEst. completion Apr 22, 2030
Research Site, London, United KingdomMultiple Sclerosis (MS) - Relapsing-remitting
This phase of the project aims to analyze the interaction between physical exercise and the phases of the menstrual cycl…
Murcia, SpainCompleted May 30, 2026